Watch students take political action

Article

The American Optometric Student Association (AOSA) and OptometryStudents.com produced a video of students and practitioners sharing their perspective on advocacy and the concerns that face the profession.

Washington, DC- The American Optometric Student Association (AOSA) and OptometryStudents.com produced a video of students and practitioners sharing their perspective on advocacy and the concerns that face the profession.

More than 250 AOSA members traveled to Washington, DC, for the American Optometric Associations’ Congressional Advocacy Conference in Washington, D.C. 

AOA produced an additional short video offering a broader perspective on the Congressional Advocacy Conference.

The AOSA’s magazine, Foresight, has coverage of the legislative agenda for the conference, which included lobbying for the National Health Service Corps Improvement Act (HR 920/S1445) and the Optometric Equity in Medicaid Act (HR 855).

Recent Videos
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
© 2025 MJH Life Sciences

All rights reserved.